PG02: Fertility Preservation and Beyond: Do the 2006 ASCO Guidelines Reflect The Current State Of Practice And Technologic Advances?
Date:October 20,
2012
Time:8:15 am - 5:00 pm
Location:Room 6E - San Diego Convention Center
Presenters
Nicole L. Noyes, M.D. (Chair), NYU School of Medicine
Lynn M. Westphal, M.D. (Co-Chair), Stanford University School of Medicine
Nadeem R. Abu-Rustum, M.D., Memorial Sloan Kettering Cancer Center
Isabelle Demeestere, M.D., Ph.D., University Libre de Bruxelles
Supporters
Developed in Cooperation with the Fertility Preservation Special Interest Group
ACGME COMPETENCY
Systems-based practice
NEEDS ASSESSMENT AND COURSE DESCRIPTION
In 2006, the American Society of Clinical Oncology (ASCO) formed an expert panel to develop guidelines for practicing oncologists regarding available fertility preservation methods and related issues in people treated for cancer. Despite publication of these guidelines, the degree to which practicing oncologists adhere to the recommendations is still unclear. It does appear, however, that awareness in the lay community is improving due to advocacy groups such as Livestrong, Fertile Hope and Fertile Action, and that referrals to reproductive specialists for fertility preservation in cancer patients are increasing. Since 2006, rapid advancements in the field of fertility preservation, particularly in oocyte and ovarian tissue cryopreservation, have created a need for more educational access regarding this topic.
This live course is aimed at all health care professionals whose practices include patients considering fertility preservation options. Current medical evidence will be presented to help participants integrate the latest technology and information into their clinical practices and provide guidance in managing this complicated patient population. Topics discussed will include recent advances in oocyte and ovarian tissue cryopreservation, fertility preservation ethical challenges, and fertility-sparing options for cancer patients.
LEARNING OBJECTIVES
At the conclusion of this course, participants should be able to:
- Summarize the current status of available fertility preservation options, including outcomes and applications, as it relates to individual cancer diagnoses.
- Describe recent advances in oocyte and ovarian tissue cryopreservation, including in vitro maturation from excised tissue.
- Discuss post-cancer treatment parenthood options, as well as ethical considerations in challenging fertility preservation scenarios.
- Summarize the current status of fertility-sparing options available to young women and men in the setting of cancer.